Wed, October 30, 2019
Tue, October 29, 2019
Mon, October 28, 2019

Douglas Tsao Initiated (TBPH) at Strong Buy and Held Target at $25 on, Oct 29th, 2019

Douglas Tsao of HC Wainwright & Co., Initiated "Theravance Biopharma, Inc." (TBPH) at Strong Buy and Held Target at $25 on, Oct 29th, 2019.

Douglas, nor any peers, have made any analyst calls on TBPH in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30